A Trial of Lopinavir-Ritonavir in Covid-19
- PMID: 32369285
- DOI: 10.1056/NEJMc2008043
A Trial of Lopinavir-Ritonavir in Covid-19
Comment in
-
A Trial of Lopinavir-Ritonavir in Covid-19. Reply.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369286 No abstract available.
Comment on
-
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187464 Free PMC article. Clinical Trial.
Similar articles
-
A Trial of Lopinavir-Ritonavir in Covid-19.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369284 No abstract available.
-
A Trial of Lopinavir-Ritonavir in Covid-19.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369283 No abstract available.
-
A Trial of Lopinavir-Ritonavir in Covid-19.N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. N Engl J Med. 2020. PMID: 32369282 No abstract available.
-
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861965 Free PMC article. Review.
-
BET 1: Lopinavir-ritonavir and COVID-19.Emerg Med J. 2020 Jul;37(7):450-451. doi: 10.1136/emermed-2020-210221.2. Emerg Med J. 2020. PMID: 32616658 Review. No abstract available.
Cited by
-
Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives.J Clin Med. 2020 Jun 30;9(7):2050. doi: 10.3390/jcm9072050. J Clin Med. 2020. PMID: 32629768 Free PMC article. Review.
-
Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients.Eur J Clin Pharmacol. 2021 Mar;77(3):389-397. doi: 10.1007/s00228-020-03020-w. Epub 2020 Oct 13. Eur J Clin Pharmacol. 2021. PMID: 33048175 Free PMC article.
-
Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects.Front Immunol. 2021 Feb 5;11:616595. doi: 10.3389/fimmu.2020.616595. eCollection 2020. Front Immunol. 2021. PMID: 33613542 Free PMC article. Review.
-
COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.Med Res Rev. 2021 Jan;41(1):5-28. doi: 10.1002/med.21728. Epub 2020 Aug 30. Med Res Rev. 2021. PMID: 32864815 Free PMC article. Review.
-
Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies.Intervirology. 2020;63(1-6):2-9. doi: 10.1159/000512141. Epub 2020 Oct 23. Intervirology. 2020. PMID: 33099545 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources